An Australian stem cell and regenerative medicine company

ASX Announcements

17 Nov 2016 Appendix 3Y x 4
17 Nov 2016 Appendix 3B
15 Nov 2016 Results of AGM
15 Nov 2016 AGM Presentation
15 Nov 2016 Cynata Receives $1.749m R&D Tax Incentive Refund
31 Oct 2016 Activities Report & Appendix 4C
16 Oct 2016 Efficacy for CYP MSC Technology in Preclinical Asthma Study
13 Oct 2016 Annual Report to Shareholders
13 Oct 2016 Notice of Annual General Meeting/Proxy Form
19 Sep 2016 UK Regulatory Authority Approves Cynata GvHD Clinical Trial
11 Sep 2016 Expiry of Unlisted Options
09 Sep 2016 Appendix 3Y-Stewart Washer
06 Sep 2016 Corporate Presentation
05 Sep 2016 CYP Determines not to proceed with Regience Investment Offer
05 Sep 2016 CYP & FUJIFILM Sign Non-Binding Terms Sheet
02 Sep 2016 Trading Halt Request
19 Aug 2016 Appendix 4G
19 Aug 2016 Appendix 4E & Financial Statements
17 Aug 2016 Expiry of Unlisted Options
31 Jul 2016 Cynata Files Application to Commence Phase 1 Clinical Trial
29 Jul 2016 Activities Report & Appendix 4C
29 Jun 2016 Cynata Receives Investment Offer from Regience
20 Jun 2016 Cynata Prepares for Phase 1 Clinical Trial
09 Jun 2016 Initial Director's Interest Notice
08 Jun 2016 Cynata Appoints Paul K Wotton Ph.D. to Board of Directors
08 May 2016 Cynata Enters Agreement with apceth GmbH & Co KK
05 May 2016 CYP Manufactures CT Product; Files Further Patent Application
02 May 2016 Decision to Grant Patent for Cymerus MSC Technology in Japan
29 Apr 2016 Cynata & Regience Extend Entitlement Period
06 Apr 2016 Compelling Results from Pre-Clinical Stem Cell Study in GvHD
02 Mar 2016 Cynata Enters Agreement for Strategic Alliance in Japan
15 Feb 2016 Cyanta Receives $930k R&D Tax Incentive Refund
27 Jan 2016 CYP Receives Favourable Advice from UK Regulatory Authority
11 Jan 2016 Cynata CLI Study Published in Peer Reviewed Journal
16 Dec 2015 Cynata Enters Letter of Intent for a Commercial Partnership
07 Dec 2015 Rodman & Renshaw Initiates Cynata Research Coverage
02 Dec 2015 CYP Enters Letter of Intent for Strategic Alliance in Japan
30 Nov 2015 Expiry of Unlisted Options
10 Nov 2015 Results of Annual General Meeting
05 Nov 2015 Restricted Securities to be Released from Escrow
04 Nov 2015 Cynata Engages CRO to Conduct GvHD Clinical Trial
13 Oct 2015 CYP in Major New Collaboration for Cell Therapy for Cancer
05 Oct 2015 Notice of Annual General Meetin/Proxy Form
06 Sep 2015 Cynata to Present at Rodman & Renshaw Investment Conference
02 Sep 2015 SeeThruEquity Initiates Cynata Research Coverage
20 Aug 2015 Appendix 4G
29 Jul 2015 Cynata in Heart Disease Collaboration with Uni of Sydney
16 Jul 2015 Information Required Under Listing Rule 3.10.5A
16 Jul 2015 Appendix 3B
14 Jul 2015 Section 708A Notice